TY  - GEN
AU  - Shen,Qiu-Dan
AU  - Zhu,Hua-Yuan
AU  - Wang,Li
AU  - Fan,Lei
AU  - Liang,Jin-Hua
AU  - Cao,Lei
AU  - Wu,Wei
AU  - Xia,Yi
AU  - Li,Jian-Yong
AU  - Xu,Wei
TI  - Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial
SN  - 2352-3026
PY  - 2018///1004
KW  - Aged
KW  - Aged, 80 and over
KW  - Antigens, CD20
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Rituximab
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1016/S2352-3026(18)30054-1
ER  -